INS and type 2 diabetes mellitus: Notably, compared with the non-MetS T2D, the MetS T2D group showed significantly increased weight, BMI and WC, elevated glucose and insulin levels during fasting and OGTT, greater insulin resistance and β-cell dysfunction, elevated blood pressure as well as higher concentration of fasting TG, and lower HDL-C levels (all P values < 0.0001).